HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants

BACKGROUND: In China, the combination of homoharringtonine, cytarabine, and G-CSF (HAG) has been extensively applied for treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). METHODS: We performed a meta-analysis of 2,314 patients (AML, n = 1754; MDS, n = 560) to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Mixue, Jiang, Qi, Li, Li, Zhu, Jingjing, Zhu, Lixia, Zhou, De, Zheng, Yanlong, Yang, Xiudi, Zhu, Mingyu, Sun, Jianai, Xie, Wanzhuo, Ye, Xiujin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051946/
https://www.ncbi.nlm.nih.gov/pubmed/27706258
http://dx.doi.org/10.1371/journal.pone.0164238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051946/
https://www.ncbi.nlm.nih.gov/pubmed/27706258
http://dx.doi.org/10.1371/journal.pone.0164238

Ejemplares similares